1. Home
  2. CLWT vs VTGN Comparison

CLWT vs VTGN Comparison

Compare CLWT & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CLWT

Euro Tech Holdings Company Limited

N/A

Current Price

$1.18

Market Cap

11.3M

ML Signal

N/A

Logo VistaGen Therapeutics Inc.

VTGN

VistaGen Therapeutics Inc.

N/A

Current Price

$0.17

Market Cap

9.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CLWT
VTGN
Founded
1971
1998
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Professional and commerical equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3M
9.5M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
CLWT
VTGN
Price
$1.18
$0.17
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
★ $1.00
AVG Volume (30 Days)
★ 1.5M
751.6K
Earning Date
04-30-2026
11-16-2026
Dividend Yield
★ 11.20%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
★ N/A
N/A
Revenue This Year
N/A
$33.96
Revenue Next Year
N/A
N/A
P/E Ratio
$17.56
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.99
$0.17
52 Week High
$2.68
$5.14

Technical Indicators

Market Signals
Indicator
CLWT
VTGN
Relative Strength Index (RSI) 40.70 34.95
Support Level $1.10 N/A
Resistance Level $1.36 $0.32
Average True Range (ATR) 0.08 0.01
MACD -0.01 0.00
Stochastic Oscillator 11.79 5.96

Price Performance

Historical Comparison
CLWT
VTGN

About CLWT Euro Tech Holdings Company Limited

Euro Tech Holdings Co Ltd is mainly a distributor of a wide range of water treatment equipment, laboratory instruments, analyzers, test kits, and related supplies, and power generation equipment, including recorders and power quality analyzers. The Company acts as an exclusive or non-exclusive distributor for manufacturers of such equipment to commercial customers and governmental agencies in Hong Kong and mainland China, as well as commercial customers in Macau. It has two operating segments: Trading and manufacturing, which generate maximum revenue and act as a distributor of water treatment equipment, laboratory instruments, analyzers, test kits, related supplies, and power generation equipment; and the Engineering segment. The Company generates maximum revenue from the PRC.

About VTGN VistaGen Therapeutics Inc.

Vistagen Therapeutics Inc is a late clinical-stage therapeutics company focused on developing and commercializing medicines for patients with social anxiety disorder, depression, menopausal hot flashes, psychomotor impairment due to mental fatigue, and cancer cachexia. The company is engaged in developing intranasal product candidates called pherines, which leverage the understanding of nose-to-brain neurocircuitry. Vistagen's pherine pipeline consists of various product candidates like: Fasedienol, Itruvone, PH15, Refisolone, and PH284, which are being developed to provide treatment for a variety of disorders. Additionally, it is seeking potential partners for the further clinical development and commercialization of an oral drug candidate, AV-101, to treat certain neurological disorders.

Share on Social Networks: